Results 181 to 190 of about 1,702,455 (203)
Some of the next articles are maybe not open access.
Therapeutic Use of Thrombopoietin Receptor Agonists
2017Discoveries throughout the twentieth century have forged our understanding of platelet production and including the variables involved in regulating the growth and maturation of megakaryocytes (Kuter, Br J Haematol 165:248–58, 2014). Thrombopoietin (TPO) is the premier growth factor involved in platelet production.
Michael D. Tarantino, Sarah Chalmers
openaire +1 more source
Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia
The Lancet Haematology, 2022Maria L, Lozano, Francesco, Rodeghiero
openaire +2 more sources
The Structure, Function, and Clinical Use of the Thrombopoietin Receptor Agonist Avatrombopag
Blood Reviews, 2022David John Kuter
exaly
Thrombopoietin-receptor agonists in children with immune thrombocytopenia
The Lancet, 2015Cindy E, Neunert, Rachael F, Grace
openaire +2 more sources
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
New England Journal of MedicineGeorge, Goshua, Alfred Ian, Lee
openaire +2 more sources
Eltrombopag: The Discovery of a Second Generation Thrombopoietin-Receptor Agonist
Expert Opinion on Drug Discovery, 2009Roberto Stasi
exaly